PROTAGONIST THERAPEUTICS INC

Ticker: PTGX CUSIP: 74366E102 Class: Common Stock

MACKENZIE FINANCIAL CORP's Holding History (CIK: 0000919859)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 3,648 Value ($000) $318 Avg Close $81.85 Range $62.24 - $96.54
Q3 2025
Shares 4,064 Value ($000) $270 Avg Close $56.84 Range $49.38 - $68.26
Q2 2025
Shares 22,457 Value ($000) $1,241 Avg Close $47.99 Range $39.60 - $57.70
Q1 2025
Shares 22,698 Value ($000) $1,098 Avg Close $41.90 Range $33.70 - $60.60
Q4 2024
Shares 21,349 Value ($000) $692 Avg Close $43.60 Range $33.31 - $48.89
Q3 2024
Shares 7,774 Value ($000) $350 Avg Close $40.40 Range $32.50 - $48.00
Q2 2023
Shares 12,745 Value ($000) $284 Avg Close $25.03 Range $17.64 - $30.10
Q1 2023
Shares 27,504 Value ($000) $633 Avg Close $16.79 Range $10.62 - $25.69